Literature DB >> 22212219

Update: APOR.

Peter H Wiernik1.   

Abstract

Mesh：

Year:  2011        PMID： 22212219      PMCID： PMC5439830          DOI： 10.1111/j.1752-8062.2011.00359.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN： 1752-8054            Impact factor:   4.689


× No keyword cloud information.
  3 in total

1.  A population-based assessment of specialty physician involvement in cancer clinical trials.

Authors:  Carrie N Klabunde; Nancy L Keating; Arnold L Potosky; Anita Ambs; Yulei He; Mark C Hornbrook; Patricia A Ganz
Journal:  J Natl Cancer Inst       Date:  2011-02-11       Impact factor: 13.506

2.  Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program Experience.

Authors:  Frank Vicini; Joyce Nancarrow-Tull; Chirag Shah; Gary Chmielewski; Monty Fakhouri; Stacey A Sitarek; Claire T Feczko; Carol Brzozowski; David L Felten
Journal:  Cancer       Date:  2011-03-31       Impact factor: 6.860

3.  Intention, needs, and expectations of cancer patients participating in clinical trials.

Authors:  Lan-Hsiang Wang; Yun-Fang Tsai; Jen-Shi Chen; Pei-Kwei Tsay
Journal:  Cancer Nurs       Date:  2011 Mar-Apr       Impact factor: 2.592
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.